IP Library Granted Patent US 9,938,506
Granted Patent B2
US 9,938,506 · App. 14/770,328 · Granted Apr 10, 2018

Bacteriophage and antibacterial composition comprising the same

Inventors: Hyo Seel Seo (Wonju-si, KR); Eun Mi Shin (Seoul, KR); Gi Duk Bae (Seoul, KR); Jae Won Kim (Yongin-si, KR)
Assignee: CJ CHEILJEDANG CORPORATION
C12N7/00A01N63/00A23K50/75A61K35/76C11D3/48C12N2795/00021C12N2795/00031C12N2795/00032C12N2795/10221C12N2795/10222C12N2795/10231
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,938,506
App. No.
14/770,328
Granted
Apr 10, 2018
Kind
B2
Abstract

Provided is a novel bacteriophage ΦCJ23 (KCCM11365P). In addition, the present invention relates to an antibacterial composition including the bacteriophage ΦCJ23 (KCCM11365P) as an active ingredient. Further, provided is a method of preventing and/or treating infectious diseases by avian pathogenic Escherichia coli (APEC) in birds using the bacteriophage ΦCJ23 (KCCM11365P) or the antibacterial composition containing the bacteriophage ΦCJ23 (KCCM11365P) as an active ingredient.

Claims (25)

1. A method of treating an infectious disease caused by APEC, comprising administering, to a bird, a composition comprising a bacteriophage ΦCJ23 (KCCM11365P), wherein the bacteriophage has a concentration between 5×10 2 and 5×10 2 PFU/ml in the composition.

2. The method according to claim 1 , wherein the infectious disease is avian colibacillosis.

3. A method of feeding comprising:

feeding, to an animal, a composition comprising a bacteriophage ΦCJ23 (KCCM11365P) and at least one material other than the bacteriophage, wherein the bacteriophage's concentration in the composition is from 5×10 2 and 5×10 12 PFU/ml.

4. A method of preparing an animal feed composition, the method comprising:

providing a bacteriophage composition comprising a bacteriophage having the nucleic acid sequence of SEQ ID NO: 1; and

mixing the bacteriophage composition with an animal feed base to provide the animal feed composition such that the animal feed composition has a concentration of the bacteriophage between 5×10 2 and 5×10 12 PFU/ml.

5. The method of claim 4 , wherein the bacteriophage composition prior to mixing is in powder or liquid, wherein the animal feed composition further comprises one or more additives selected from the group consisting of an amino acid, a vitamin, an enzyme, a probiotic, a flavoring agent, a non-protein nitrogen compound, a silicate, a buffer, a coloring agent, an extractant and an oligosaccharide.

6. A method of feeding, the method comprising: preparing the animal feed composition according to the method of claim 4 ; and feeding, to an animal, the animal feed composition as a feed.

7. A method of preparing a drinking water composition, the method comprising:

providing a bacteriophage composition comprising a bacteriophage having the nucleic acid sequence of SEQ ID NO: 1; and

mixing the bacteriophage composition with drinking water to provide the drinking water composition such that the drinking water composition has a concentration of the bacteriophage between 5×10 2 and 5×10 12 PFU/ml.

8. The method of claim 7 , wherein the bacteriophage composition prior to mixing is in powder or liquid, wherein the drinking water composition further comprises one or more additives selected from the group consisting of an amino acid, a vitamin, an enzyme, a probiotic, a flavoring agent, a non-protein nitrogen compound, a silicate, a buffer, a coloring agent, an extractant and an oligosaccharide.

9. A method of providing drinking water, the method comprising:

preparing the drinking water composition according to the method of claim 7 ; and

providing, to an animal, the drinking water composition as drinking water.

10. The method of claim 1 , wherein the bacteriophage comprises the nucleic acid sequence of SEQ ID NO: 1.

11. The method of claim 2 , wherein the bacteriophage comprises the nucleic acid sequence of SEQ ID NO: 1.

12. The method of claim 3 , wherein the bacteriophage comprises the nucleic acid sequence of SEQ ID NO: 1.

13. The method of claim 4 , wherein the bacteriophage having the nucleic acid sequence of SEQ ID NO: 1 comprises ΦCJ23 (KCCM11365P).

14. The method of claim 5 , wherein the bacteriophage having the nucleic acid sequence of SEQ ID NO: 1 comprises ΦCJ23 (KCCM11365P).

15. The method of claim 6 , wherein the bacteriophage having the nucleic acid sequence of SEQ ID NO: 1 comprises ΦCJ23 (KCCM11365P).

16. The method of claim 7 , wherein the bacteriophage having the nucleic acid sequence of SEQ ID NO: 1 comprises ΦCJ23 (KCCM11365P).

17. The method of claim 8 , wherein the bacteriophage having the nucleic acid sequence of SEQ ID NO: 1 comprises ΦCJ23 (KCCM11365P).

18. The method of claim 9 , wherein the bacteriophage having the nucleic acid sequence of SEQ ID NO: 1 comprises ΦCJ23 (KCCM11365P).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2015
From: SEO, HYO SEEL; SHIN, EUN MI; BAE, GI DUK; KIM, JAE WON
To: CJ CHEILJEDANG CORPORATION
Reel/Frame 036526/0437 →
Priority Claims (1)
KR 10-2013-0021501 · Feb 27, 2013 · national
Continuity (1)
Related Publication 20160083695A1 · Mar 24, 2016